Oren Gilad
FounderChief Executive Officer, President at Aprea
Ambler, Pennsylvania, United States
FoundedAtrin Pharmaceuticals
Find your path to Oren
33 people in our graph share verified history with Oren — schools, employers, funds. One of them is your warm intro.
Michael KalosunlockedOren: together at University of Pennsylvania School of Medicine (2008–2011)
×11Oren: together at University of Pennsylvania School of Medicine
Chief Executive Officer, President at Aprea
Intro paths
→
In turn, Oren can intro founders to Aprea's investors below.
Experience
- Aprea TherapeuticsPresident and CEOcurrent2022 — presentDoylestown, Pennsylvania, United States
- ATRIN PHARMACEUTICALSCEO2011 — 2022Doylestown PA
- University of Pennsylvania School of MedicinePost Doctoral Fellow2006 — 2011
Skills & more
CancerCellBiotechnologyPharmaceuticalsMolecular BiologyCell BiologyClinical ResearchGenomicsCell CultureWestern BlottingPCRImmunohistochemistry
+12 more
GeneticsFlow CytometryConfocal MicroscopyCell Based AssaysMolecular CloningImmunoprecipitationMicroscopyIn VivoAnimal ModelsqPCRDNATissue CultureFrom Oren's professional profile.
Frequently asked questions
- Who is Oren Gilad?
- Chief Executive Officer, President at Aprea
- Where does Oren Gilad work?
- Oren Gilad is Founder of Atrin Pharmaceuticals and Chief Executive Officer, President at Aprea.
- What companies did Oren Gilad found?
- Oren Gilad founded Atrin Pharmaceuticals.
- Where did Oren Gilad go to school?
- Oren Gilad studied at University of California, Davis (Ph.D, Pathology).
Same school
Also attended University of California, Davis352
Charles CallSLP & Venture Partner at Cottonwood Technology FundDavid PhuController at Felicis VenturesTeresa ChanChief Financial Officer at Felicis VenturesBryan EglanDirector of Business Development at Menlo VenturesDennisDirector of Trading at Pantera CapitalScott MaxwellInvestor at OpenView Venture Partners
+ 346 more
Shared employers
Also worked at Aprea Therapeutics2
Also worked at ATRIN PHARMACEUTICALS2
Also worked at University of Pennsylvania School of Medicine34
Eric ShanAssociate at 7wire VenturesTimothy ChangManaging Director at Goodwater CapitalMichael KalosInvestor at 82VSConnie LiPrincipal at F-Prime Capital PartnersNikhil AnanthPrincipal at F-Prime Capital PartnersShreeram AradhyeInvestor at Novartis Venture Fund
+ 28 more



















